Giorgio Arnaldi

14PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEndocrinologyTraditional Chinese medicine and treatmentsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 28, 2026
Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.

|Mar 28, 2026
Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer.

Giuseppe Siragusa, Laura Tomasello, Mattia Biondo

|Dec 30, 2025
SOX2/SOX17 Molecular Switching by Polyphenols to Promote Thyroid Differentiation in 2D and 3D Models of Anaplastic Thyroid Cancer †.

Fabiola Vaglica, Mattia Biondo, Giuseppe Siragusa

|Dec 23, 2025
The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis.

Gianmaria Salvio, Alessandro Ciarloni, Nairus Aboud

|Dec 11, 2025
Osteoporosis and Fracture Risk in Ovarian Cancer: Beyond the Oncologic Burden.

Mariagrazia Irene Mineo, Giorgio Arnaldi, Valentina Guarnotta

|Dec 09, 2025
Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology.

Filippo Ceccato, Massimo Terzolo, Federico Gatto

Pageof 3

Frequent Collaborators

4 joint publications

Valentina Guarnotta

3 joint publications

Marianna Martino

3 joint publications

Laura Tomasello

3 joint publications

Giuseppe Pizzolanti